About vildaglipiti n
Dipeptidyl peptidase-4 (DPP-4) inhibitor
Used for
- Type 2 diabetes, alone or with other diabetes medicines
Usual adult dose
Usually 50 mg once or twice daily; dose depends on other medicines and kidney function.
Common side effects
- Headache
- Dizziness
- Nausea
- Low blood sugar, especially with insulin or sulfonylureas
Important warnings
- Not for type 1 diabetes or diabetic ketoacidosis.
- Rarely, can cause pancreatitis or serious allergic reactions.
- May cause liver problems; liver tests are usually checked before and during treatment.
- Dose reduction may be needed with kidney impairment.
Pregnancy
Generally not recommended; human pregnancy information is limited.
Breastfeeding
Not recommended because safety information is limited.
Interactions
- Insulin or sulfonylureas can increase low-blood-sugar risk.
- Some medicines, including corticosteroids, may affect blood-glucose control.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.